Leishmaniasis, Cutaneous clinical trials

The registry lists 103 studies for Leishmaniasis, Cutaneous across more than 10 countries. 18 are recruiting or about to start. 94 of them are mainly about Leishmaniasis, Cutaneous (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its narrower condition Leishmaniasis, Mucocutaneous too: 114 studies, 20 open.

Get an email when these change. Save the Leishmaniasis, Cutaneous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 64
Terminated: 10
Recruiting: 10
Not yet recruiting: 7
Status unknown: 7
No longer available: 2

Phase

Phase 2: 41
Phase 3: 24
Phase 1: 10
Phase 4: 4
Early Phase 1: 1

Where

Brazil: 17
Colombia: 13
Ethiopia: 10
United States: 9
Bolivia: 7
Peru: 6

Who runs them

U.S. Army Medical Research and Development Command (12) · Institute of Tropical Medicine, Belgium (9) · Hospital Universitário Professor Edgard Santos (9) · Drugs for Neglected Diseases (6) · Access to Advanced Health Institute (AAHI) (4) · Centro Internacional de Entrenamiento e Investigaciones Médicas (4) · Universidad de Antioquia (4) · University of York (4)

What is being tested here

Drugs under test in Leishmaniasis, Cutaneous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Miltefosine	2	6	14
Paromomycin	1	3	3
Arnicae flos extract	1	1	2
Liposomal amphotericin B	1	1	2
Amphotericin B	1	1	2
Pentamidine	1	1	1
Fusidic Acid	1	1	1
Tofacitinib	1	1	1
Levofloxacin	1	0	1
Ciprofloxacin	1	0	1

Coming up

5phase 3 studies under way

3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Mar 2027Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia · Phase 3 · Institute of Tropical Medicine, Belgium
Dec 2026Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis · Institute of Tropical Medicine, Belgium
Mar 2027Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup · Armauer Hansen Research Institute, Ethiopia

Who these studies take

Of the 10 Leishmaniasis, Cutaneous studies recruiting now, 3 (30%) set no upper age limit and 3 (30%) stop at 75 or younger. 6 (60%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	3 (30%)	3 (30%)
18	9 (90%)	9 (90%)
30	9 (90%)	9 (90%)
40	9 (90%)	9 (90%)
50	9 (90%)	9 (90%)
65	8 (80%)	8 (80%)
75	7 (70%)	7 (70%)
85	4 (40%)	4 (40%)

Across all 103 studies, recruiting or not: 50% stop at 75 or younger and 44% at 65; 57% take children; 0% are for women only and 2% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 103. Browse all 103 → or search them.